-- Access the complete report at:
http://www.strategymrc.com/report/recombinant-dna-rdna-technology-market
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Recombinant DNA (rDNA) Technology Market, By Component
5.1 Introduction
5.2 Cloning Vector
5.2.1 Phage
5.2.2 Bacterial Artificial Chromosome (BAC)
5.2.3 Human Artificial Chromosome (HAC)
5.2.4 Yeast Artificial Chromosome (YAC)
5.2.5 Cosmid
5.2.6 Plasmid
5.3 Expression System
5.3.1 Baculovirus/Insect
5.3.2 Bacteria
5.3.3 Mammalian
5.3.4 Yeast
5.3.5 Other Expression System
6 Global Recombinant DNA (rDNA) Technology Market, By Product
6.1 Introduction
6.2 Non-medical
6.2.1 Specialty Chemicals
6.2.2 Biotech Crops
6.2.3 Other Non-Medical Technology
6.3 Medical
6.3.1 Human Protein
6.3.2 Therapeutic Agent
6.3.3 Vaccine
7 Global Recombinant DNA (rDNA) Technology Market, By Application
7.1 Introduction
7.2 Health & Disease
7.2.1 Human
7.2.2 Animal
7.3 Food & Agriculture
7.4 Environment
7.5 Other Applications
8 Global Recombinant DNA (rDNA) Technology Market, By End User
8.1 Introduction
8.2 Academic & Research Institutes
8.3 Pharmaceutical & Biotech Entities
8.4 Other End Users
9 Global Recombinant DNA (rDNA) Technology Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 F. Hoffmann-La Roche Ltd
11.2 Monsanto Company
11.3 Amgen Inc
11.4 Biocon
11.5 Biogen
11.6 Eli Lilly and Company
11.7 GenScript
11.8 GlaxoSmithKline plc
11.9 Horizon Discovery Group PLC
11.10 Merck & Co
11.11 New England Biolabs.
11.12 Novartis AG
11.13 Novo Nordisk A/S
11.14 Pfizer Inc
11.15 Profacgen
Request for sample here:
http://www.strategymrc.com/report/recombinant-dna-rdna-technology-market/request-sample
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Follow us on Twitter: https://twitter.com/StratisticsMRC
Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile
About Stratistics MRC
We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.
Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.
Contact Info:
Name: James Lamb
Email: Send Email
Organization: Stratistics Market Research Consulting Pvt Ltd
Phone: +1-301-202-5929
Website: http://www.strategymrc.com/
Release ID: 270863
Google
RSS